Human normal immunoglobulins

Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 26, Status: Authorised

Patients' and Consumers' Working Party

Agenda of the PRAC meeting 29 September - 2 October 2025

Minutes of the HMPC meeting 7-9 July 2025

Human medicines European public assessment report (EPAR): Zurzuvae, zuranolone, Status: Authorised

Human medicines European public assessment report (EPAR): Empliciti, elotuzumab, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): ellaOne, ulipristal acetate, Date of authorisation: 15/05/2009, Revision: 36, Status: Authorised